(Q38474625)

3 September 2017

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma (English)

1 reference

3 September 2017

Ross JS

1

1 reference

3 September 2017

Sheehan CE

2

1 reference

3 September 2017

Hayner-Buchan AM

3

1 reference

3 September 2017

Ambros RA

4

1 reference

3 September 2017

Kallakury BV

5

1 reference

3 September 2017

Kaufman RP Jr

6

1 reference

3 September 2017

Fisher HA

7

1 reference

3 September 2017

Rifkin MD

8

1 reference

3 September 2017

Muraca PJ

9

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

3 September 2017

1 reference

3 September 2017

79

1 reference

3 September 2017

2162-2170

1 reference

3 September 2017

11

1 reference

describes a project that uses

3 September 2017

fluorescence in situ hybridization

1 reference

based on heuristic

inferred from title

cites work

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Gene amplifications in advanced-stage human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

C-erbB-2 immunostaining: problems with interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Transfected neu oncogene induces human prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Oncogene amplifications in early-stage human prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970601%2979%3A11%3C2162%3A%3AAID-CNCR14%3E3.0.CO%3B2-U

10.1002/(SICI)1097-0142(19970601)79:11<2162::AID-CNCR14>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference